Skip to main content
See every side of every news story
Published • loading... • Updated

Tumor to the Pancreas, Appeal of 11 Associations for Free Access to the Daraxonrasib: Bertolaso "at Their Side"

Summary by canaledieci.it
(Adnkronos) "Facilitate free access to Daraxonrasib, the medicine of hope against metastatic pancreatic cancer, also activating in Italy an ad hoc program financed by the company producing Rasonque*. It is the appeal signed by 11 Italian organizations committed to the protection of cancer patients, which collects the support of Lombardy. On the World Cancer Day [...]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

5 Articles

canaledieci.itcanaledieci.it
Reposted by
newsbiella.itnewsbiella.it

(Adnkronos) "Facilitate free access to Daraxonrasib, the medicine of hope against metastatic pancreatic cancer, also activating in Italy an ad hoc program financed by the company producing Rasonque*. It is the appeal signed by 11 Italian organizations committed to the protection of cancer patients, which collects the support of Lombardy. On the World Cancer Day [...]

Rec News | Lontani dal mainstreamRec News | Lontani dal mainstream
Reposted by
notizie.itnotizie.it

(Adnkronos) "Facilitate free access to Daraxonrasib, the medicine of hope against metastatic pancreatic cancer, also activating in Italy an ad hoc program financed by the producer of Rasonque*. It is the appeal signed by 11 Italian organizations engaged in the protection of cancer patients, which collects the support of Lombardy. On the World Cancer Day of [...] L'articolo Tumor to the pancreas, appeal of 11 associations for free access to Darax…

(The following text is taken in full from the press note sent to the Agency Opinion) ///// Regione Lombardia is ready to support the proposal made by eleven Italian associations of patients with pancreatic cancer to facilitate free access to Daraxonrasib, a new drug developed by the US company Revolution Medicines for the treatment of pancreatic metastatic cancer. The [...]

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Agenzia giornalistica Opinione broke the news on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal